Related Experiment Video
Updated: Jun 5, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer
Yoshito Hirata1, Mario di Bernardo, Nicholas Bruchovsky
1Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan. yoshito@sat.t.u-tokyo.ac.jp
Abstract:
We propose a method for achieving an optimal protocol of intermittent androgen suppression for the treatment of prostate cancer. Since the model that reproduces the dynamical behavior of the surrogate tumor marker, prostate specific antigen, is piecewise linear, we can obtain an analytical solution for the model. Based on this, we derive conditions for either stopping or delaying recurrent disease. The solution also provides a design principle for the most favorable schedule of treatment that minimizes the rate of expansion of the malignant cell population.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen: Individualization
Dosage Regimens: Designs and Approaches
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...

